Choosing reagents for proteins that exist in isoforms and in circulation: why a troponin i antibody has to name the isoform because the cardiac and skeletal forms are different proteins, what a myh7 antibody, a myh9 antibody, a myosin heavy chain antibody, a titin antibody and a myod1 antibody demand of extraction in muscle, how an acta2 antibody, an alpha sma antibody and an alpha smooth muscle actin antibody name the same target across three spellings and why a b-actin antibody, an anti actin antibody, a beta tubulin antibody and an acetylated alpha tubulin antibody or acetylated tubulin antibody are loading references with their own pitfalls, where a bnp antibody, an hcn4 antibody and an enos antibody sit in cardiac and vascular work, what a von willebrand factor antibody, a prothrombin antibody, a factor viii antibody, a factor ix antibody and a tissue factor antibody require of plasma handling, and how an albumin antibody, a transthyretin antibody, a ttr antibody, an alpha 1 antitrypsin antibody, a ceruloplasmin antibody, a hemoglobin antibody, a glycophorin a antibody, a myoglobin antibody, a leptin antibody, a gdf15 antibody, a klotho antibody, an osteocalcin antibody and an mgp antibody behave when the analyte is abundant

Choosing and handling

1. Name the isoform for muscle targets. Cardiac, skeletal and smooth muscle isoforms of the same protein family differ in a small number of residues. A reagent that does not state which it detects cannot support a tissue specific claim.
2. Extract muscle properly. Very large and highly cross linked muscle proteins need specialised gels and extraction, and standard sample preparation leaves them at the top of the well. Use a protocol designed for the size range.
3. Treat abundant plasma proteins as a dilution problem. Highly abundant analytes saturate immunoassays and mask everything else. Dilution series, depletion where appropriate and a clear statement of the dilution used are what make these measurements comparable.
4. Standardise blood collection. Tube type, time to processing, temperature and freeze thaw change measured concentrations, sometimes by more than the biological effect. Fix the collection protocol before the first sample.
5. Do not assume a loading control is stable. Common structural loading references change with differentiation, stress and tissue type. Total protein staining is safer, and should be shown.

Isoforms are separate proteins in practice

Sequence similarity between tissue specific isoforms is high enough that many polyclonal reagents see all of them. That is fine when the tissue is known and fatal when the point is to identify the tissue of origin.

Where tissue specificity is the claim, use a monoclonal with a stated discrimination and show it on both tissues.

Abundance changes the technique

For a protein present at high concentration, the limiting factor is never sensitivity. It is linearity, dilution accuracy and whether the assay saturates, and the useful validation is a dilution series on real samples rather than a standard curve in buffer.

Report the dilution and show that the result is dilution independent. That single check catches most of the errors in this area.

Common questions

Does a troponin reagent distinguish cardiac from skeletal?

Only if it says so. The isoforms differ at defined regions and clones vary in whether they discriminate. For any tissue specific claim the datasheet must state it explicitly.

Why does my very large muscle protein not enter the gel?

Standard acrylamide gels do not resolve proteins of that size. Low percentage or gradient gels designed for the range, and a gentler extraction, are required.

How much does blood collection matter?

Frequently more than the biology. Tube additive, time to processing and freeze thaw all change measured concentrations for several plasma analytes, which is why a fixed protocol comes before the first sample.

Browse by service class

• Compare Gene synthesis on advertised prices